Summary
Various human tumor tissues contain different growth factors. In some cases progression of tumors is paralleled by elevated levels of these substances in blood or in tumor tissue. There is evidence that these growth promoting peptides might stimulate tumor growth. The growth of most tumors was associated with insulin-like substances (MW 45 000). We isolated and purified a substance immunologically cross-reactive with insulin (SICRI) from human melanoma. We found the molecular weight of affinity purified SICRI to be approximately 120 000. Our in vitro experiments with human renal carcinoma cells and growth factors suggest an important role of these molecules in tumor progression.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Levi-Montalcini R (1952) Effect of mouse tumor transformation on the nervous system. Ann NY Acad Sci 55:330–343
Sporn MB, Todaro GJ (1980) Autocrine secretion and malignant transformation of cells. N Engl J Med 303:878–880
DeLarco JE, Todaro GJ (1978) Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci USA 75:4001–4005
Pavelić K, Vuk-Pavlović S (1983) C-peptide does not parallel increases of substances immunologically cross-reactive with insulin in non-Hodgkin lymphoma patients. Blood 61:925–928
Vuk-Pavlović S, Opara EC, Levanat S, Vrbanec D, Pavelić K (1986) Autocrine tumor growth regulation and tumor-associated hypoglycemia in murine melanoma B 16 in vivo. Cancer Res 46:2208–2212
Pavelić K, Bolanča M, Veček N, Pavelić J, Marotti T, Vuk-Pavlović S (1982) Carcinomas of the cervix and corpus uteri in humans: Stage-dependent blood levels of substance(s) immunologically cross-reactive with insulin. J Natl Cancer Inst 68:891–894
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265–275
Furlanetto RW, Underwood LE, Van Wyk JJ, D'Ercole AJ (1977) Estimation of somatomedin C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest 60:648–657
Murphy RA, Pantazis NJ, Arnason BGW, Young M (1975) Secretion of a nerve growth factor by mouse neuroblastoma cells in culture. Proc Natl Acad Sci USA 72:1895–1898
Byyny RL, Orth DN, Cohen S (1972) Radioimmunoassay of epidermal growth factor. Endocrinology 90:1261–1266
Heldin CH, Westermark B, Wasteson A (1979) Platelet-derived growth factor purification and partial characterization. Proc Natl Acad Sci USA 76:3722–3726
Pavelić K, Ferle-Vidović A, Osmak M, Vuk-Pavlović S (1981) Synthesis of immunoreactive insulin in vitro by aplastic mammary carcinoma preconditioned in diabetic mice. J Natl Cancer Inst 67:687–688
Pavelić K, Vrbanec D, Marušić S, Levanat S, Čabrijan T (1985) Autocrine tumor growth regulation by somatomedin C: An in vitro model. J Endocrinol 109:233–238
Čabrijan T, Pačarizi H, Levanat S, Vrbanec D, Pavelić J, Milković D, Spaventi R, Končar M, Baltić V, Spaventi Š, Pavelić K (1988) In: Bresciani F, King RJB, Lippman ME, Raynaud JP (eds) Prog Cancer Res Ther, vol 35. Hormones and cancer 3. Autocrine tumor growth regulation by the insulin growth factor I (IGF I) and the epidermal growth factor (EGF). Raven Press, New York
Bajzer Ž, Pavelić K, Vuk-Pavlović S (1984) Growth self-incitement in murine melanoma B 16: A phenomenological model. Science 225:930–932
Pardee AB, Campisi J, Croy RG (1985) In: Feramisco J, Ozanne B, Stiles C (eds) Cancer cells, vol 3: Growth factors and transformation: New directions: Molecular basis of growth regulation. Cold Spring Harbor Laboratory, New York, pp 389–392
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Krušlin, B., Levanat, S., Baltić, V. et al. Growth factors in human tumors. Res. Exp. Med. 189, 91–99 (1989). https://doi.org/10.1007/BF01851259
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01851259